But What If...? Regret and Prostate Cancer Treatment Choices
Prostate Cancer Foundation Canada hosts monthly Coast to Coast meetings featuring prostate cancer experts on different topics. May 2022's meeting featured Dr. Christopher Wallis speaking on prostate cancer treatment regret and decisions. Christopher J.D. Wallis is a Urologic Oncologist at the University of Toronto and Mount Sinai Hospital/University Health Network. He obtained his Doctor of Medicine from the University of British Columbia and his Doctor of Philosophy in Clinical Epidemiology & Health Care Research from the Institute of Health Policy, Management & Evaluation at the University of Toronto and completed his clinical residency in Urology at the University of Toronto affiliated hospitals and his Society of Urologic Oncology accredited fellowship training at Vanderbilt University Medical Center. His research focuses on leveraging a variety of epidemiologic techniques to understand the interaction between processes of care and patient outcomes, with a particular focus on patients with cancer and those undergoing surgery. Recently, his work has focused heavily on understanding the interplay between physician characteristics and patients’ operative outcomes. For more information on Prostate Cancer Foundation Canada (formerly Prostate Cancer Foundation BC) please visit: www.prostatecanada.ca The views, information, and opinions expressed in this video are those of the individuals involved and do not necessarily reflect the official policy or position of Prostate Cancer Foundation Canada (PCFC) or its employees. PCFC is not responsible and does not verify for accuracy any of the information contained in the videos available for watching on this site. The primary purpose of these videos is to educate and inform, but these videos do not constitute, or replace, medical or other professional advice.

Most Men with Prostate Cancer are Choosing This Instead

Surgery or Radiotherapy for Prostate Cancer? Here's What the Evidence Shows

Hormonal Therapy for Prostate Cancer

The Power Of Exercise For Prostate Cancer | Robert Newton, PHD & Q+A with Mark Moyad, MD #PCRI

Metastatic Prostate Cancer: What It Really Means (Not What You Think)

Risk Assessment of PSA Recurrent Prostate Cancer

3+4=7 #ProstateCancer | Active Surveillance vs. Focal Therapy | #MarkScholzMD #AlexScholz #PCRI

Does it Matter How You Do a Prostate Biopsy? Transperienal vs Transrectal Prostate Biopsy

What if I DON'T treat my low-risk prostate cancer?

Prostate Cancer Spreads to Bone First: Catch It Before It's Too Late

Reducing Side Effects of Hormone Therapy for Prostate Cancer | Prostate Cancer Staging Guide

Gleason 3+4 Prostate Cancer

Stop Blind Biopsies: Near-Perfect Prostate Cancer Accuracy with Dr. Mark Emberton - EP 170

Debate: Surgery vs. Brachytherapy for Intermediate and High-Risk Prostate Cancer– Brachytherapy

Intermediate risk prostate cancer

NanoKnife / Prostate Cancer Webinar with Dr. Carl Capelouto

The Podcast - Episode 101 - Mark's Prostate Cancer Experience

Short Term vs. Long Term Of Hormone Therapy For #ProstateCancer | #MarkScholzMD #AlexScholz #PCRI

Prostate cancer recurrence: Relapse after prostate cancer – which treatment helps now?

